Does Innovation drive growth? - Growth in revenue, market share, and earnings are top issues on the CXO agenda. How do top performing companies set a strategy of innovation?

The PDMA Innovation Strategy track brings together business leaders and thought leaders who can share their insights, challenges, lessons-learned, and successes on driving innovation throughout their enterprise. Attendees will gain cross-industry perspectives on strategic innovation throughout product and market lifecycle.

Learn how these executives build innovation into their global product strategy, development, and lifecycle management to drive earnings-per-share value. Hear how service and product companies deal with the challenge of effective decision making among portfolios, platforms, product roadmaps, and market opportunities. Discover best practices in developing products in compliance with national and global regulatory standards.

In our hyper-competitive, global business environment, those companies that can best develop and execute effective innovation strategies will be the leaders of the future.

Session Topics:

• Wall Street View on Innovation
• Innovation Strategy for Service Companies
• Managing and Investing in Ideation
• Strategically Aligning Supply Chain with the Development Value Chain
• Delivering Breakthrough Innovation in a Regulated Environment
• Portfolio Management and Platform Decision Making

Track Chairs:

• Tom Solazzo, Director, Pacific Region, Pittiglio Rabin Todd & McGrath (PRTM); Services Industry Lead and Commercial Lead of PRTM's Product Development Practice Area
• Bill Gerould, WW Discrete Mfg Industry Manager, Microsoft Corporation

Track Team:

• June Gidman, Strategic Research Manager, ChevronTexaco
• Ed Yu, Director, Pittiglio Rabin Todd & McGrath [Bio]
• Bob Brentin, Market Development Specialist, Dow Corning Corporation
• Mitch Beaumont, Principal, Pittiglio Rabin Todd & McGrath
• Scott Constance, Manager, Pittiglio Rabin Todd & McGrath
• Graham Milner, Executive Vice President, Global Development and Chief Branding Officer, WD-40 Company
• Derry Connolly, Director, UCSD

PANEL SESSION: Wall Street View on Innovation
Moderator:

What is the financial impact and success of innovation? In this track you will learn from leading innovators and business analysts on how they evaluate the commercial potential of innovation in terms of potential revenues, market impact, stock price, and risk management through experience, examples, best practices, and case studies.

PANEL SESSION: Innovation Strategy for Service Companies
Moderator:

Is there a difference in product vs. service innovation...especially for services delivered over complex, high-transaction IT infrastructure such as communications or financial services? How do companies that deliver such services innovate and what can others learn from their experience?

Managing and Investing in Ideation

Idea incubators come in all sizes...from small VC's that nurture new start-ups...to cross-functional teams in billion-dollar companies that cultivate new product concepts prior to feeding them into the development pipeline. How do companies of all sizes manage and invest in new product ideas? The answers may help you fill your pipeline with more...and better...products for your company's future.

Strategically Aligning Supply Chain with the Development Value Chain

Some companies are known for their product development expertise. Others excel at planning, sourcing, making, and delivering through supply chain excellence. But how do you align both of these competencies to truly distinguish your company from its competition? Hear how industry leaders use co-development techniques to partner on both the development and the supply of key product elements. And learn how product lifecycle management, and other best practices, can bridge the gap between the development and delivery sides of your business.

Delivering Breakthrough Innovation in a Regulated Environment

The challenges that biopharmaceutical companies face during drug development are relevant to other industries: balancing the need for creativity and innovation with the need for repeatable, high-quality execution. Operating in a regulated industry, of course, places a premium on reliable, high-quality execution. This is especially true of biopharmaceuticals where the products touch human lives.

Can a regulated company truly pursue an innovation-based strategy? Yes! "Regulated" need not mean "not innovative." During this session, the presenters will provide a case study about how one company successfully drives an innovative strategy while simultaneously addressing the need for repeatable processes that are compliant with regulatory obligations.

The presentation will outline the challenges and provide insight into the solutions. In particular, the presentation will address:

• Design of a product development initiative to deliver on an innovation strategy while enabling efficient, repeatable, high-quality drug product development
• Interface between innovative, "front-end" design to test hypotheses and execution processes
• Organizational and implementation approach for feeding two cultures:innovation and operational excellence

The presenters will share lessons learned and practical tips regarding how a company's management approach and processes can satisfy the dual objectives of innovation and regulatory compliance.

Portfolio Management and Platform Decision Making